XRpro Sciences Completes $8.855M Equity Financing

XRpro Sciences, Inc. (formerky known as Caldera Pharmaceuticals), a Cambridge, MA-based provider of a platform for drug discovery and development services, completed an $8.855m equity financing.

The round was led by Taglich Brothers, an investment bank in New York.

The comany intends to use the funds to continue to grow operations.

Led by Richie Cunningham, President and CEO, and Tim Tyson, Chairman, XRpro Sciences, Inc. provides a platform for drug discovery and development services featuring high throughput screening of ion channel assays for the pharmaceutical industry.
XRpro® technology directly measures the activity of a drug target, without the need for costly and artifact-causing chemical dyes or radiolabels.

FinSMEs

08/01/2015

Join the discussion